Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2nd Road, Shanghai, 200025, People's Republic of China.
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Appl Microbiol Biotechnol. 2019 Feb;103(3):1311-1324. doi: 10.1007/s00253-018-9562-8. Epub 2018 Dec 18.
Radiolabelled ligands of glucagon-like peptide 1 receptor (GLP-1R) have been used to image the GLP-1R-expressing tissues (e.g., islets and insulinoma). Here, we introduced human glucagon-like peptide 1 receptor (hglp-1r) gene as a novel radionuclide reporter gene to broaden its applications in molecular imaging in vivo. Transient and stable baculoviral vectors (BV) were re-constructed and used to transfer the hglp-1r gene or enhanced green fluorescent protein (egfp) reporter gene into the stem cells or tumor cells. Cell proliferation assay and flow cytometry analysis demonstrated that BV-mediated reporter gene transferring and expression was biosafe and highly efficient. The BV-mediated exogenous hGLP-1R in target cells showed same ligand-receptor binding characteristics compared with its counterpart in insulinoma cells. Furthermore, the ligand-receptor binding assay showed a high affinity (IC = 0.3708 nM) and robust correlation (R = 0.9264) between the fluorescein-tagged or radiolabeled ligand probes and exogenous hGLP-1R in target cells. The target cells transferred with BV-mediated hGLP-1R could be clearly visualized in nude mice by micro-PET, which was capable of the purposes of short-term tracking transplanted stem cells or long-term monitoring tumor formation. Then, the image-based analysis and bio-distribution analysis quantitatively confirmed high target-to-background ratio of hGLP-1R-expressing cells. This study also investigated the endogenous GLP-1R-expressing organs/tissues in nude mice in the hGLP-1R radionuclide reporter gene imaging. Summarily, we evaluated the utility of hglp-1r gene as a novel radionuclide reporter gene, and demonstrated that it was a favorable and promising candidate of molecular imaging tool, which would expand the spectrum of radionuclide reporter gene imaging systems.
胰高血糖素样肽 1 受体 (GLP-1R) 的放射性配体已被用于对 GLP-1R 表达组织(如胰岛和胰岛素瘤)进行成像。在此,我们引入人胰高血糖素样肽 1 受体 (hglp-1r) 基因作为新型放射性核素报告基因,以拓宽其在体内分子成像中的应用。瞬时和稳定的杆状病毒载体(BV)被重新构建并用于将 hglp-1r 基因或增强型绿色荧光蛋白(egfp)报告基因转移到干细胞或肿瘤细胞中。细胞增殖试验和流式细胞术分析表明,BV 介导的报告基因转移和表达是生物安全且高效的。目标细胞中的 BV 介导的外源性 hGLP-1R 与其在胰岛素瘤细胞中的对应物具有相同的配体-受体结合特性。此外,配体-受体结合试验表明,荧光素标记或放射性标记的配体探针与目标细胞中外源 hGLP-1R 之间具有高亲和力(IC=0.3708 nM)和强相关性(R=0.9264)。通过 micro-PET 可以清楚地观察到转染 BV 介导的 hGLP-1R 的靶细胞在裸鼠中的情况,这可以实现短期跟踪移植的干细胞或长期监测肿瘤形成的目的。然后,基于图像的分析和生物分布分析定量证实了 hGLP-1R 表达细胞的高靶背比。本研究还研究了裸鼠内源性 GLP-1R 表达器官/组织的 hGLP-1R 放射性报告基因成像。总之,我们评估了 hglp-1r 基因作为新型放射性核素报告基因的实用性,并证明它是一种有前途的分子成像工具候选者,将扩大放射性核素报告基因成像系统的范围。